Biology and Management of Salivary Gland Cancers

Spiro, 1986, Salivary neoplasms: Overview of a 35-year experience with 2,807 patients, Head Neck Surg, 8, 177, 10.1002/hed.2890080309

Batsakis, 1989, Histogenesis of salivary gland neoplasms: A postulate with prognostic implications, J Laryngol Otol, 103, 939, 10.1017/S0022215100110552

Barnes, 2005

Fordice, 1999, Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality, Arch Otolaryngol Head Neck Surg, 125, 149, 10.1001/archotol.125.2.149

Ghosh-Laskar, 2011, Mucoepidermoid carcinoma of the parotid gland: Factors affecting outcome, Head Neck, 33, 497, 10.1002/hed.21477

Murrah, 1994, Salivary duct carcinoma, Ann Otol Rhinol Laryngol, 103, 244, 10.1177/000348949410300315

Hotte, 2005, Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: A Princess Margaret Hospital phase II consortium study, J Clin Oncol, 23, 585, 10.1200/JCO.2005.06.125

Bell, 2010, Cell type-dependent biomarker expression in adenoid cystic carcinoma: Biologic and therapeutic implications, Cancer, 116, 5749, 10.1002/cncr.25541

Agulnik, 2007, Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands, J Clin Oncol, 25, 3978, 10.1200/JCO.2007.11.8612

Williams, 2007, Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: Biologic significance and potential role in therapeutic stratification of patients, Am J Surg Pathol, 31, 1645, 10.1097/PAS.0b013e3180caa099

Locati, 2009, Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs), Oral Oncol, 45, 986, 10.1016/j.oraloncology.2009.05.635

Guertin, 2007, Defining the role of mTOR in cancer, Cancer Cell, 12, 9, 10.1016/j.ccr.2007.05.008

Diegel, 2010, Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of APC and PTEN in the mouse salivary gland: Implications for human acinic cell carcinoma, Cancer Res, 70, 9143, 10.1158/0008-5472.CAN-10-1758

Nasser, 2003, Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors, Am J Clin Pathol, 119, 801, 10.1309/RVTP1G0Q727WJUQD

Jaspers, 2011, Androgen receptor-positive salivary duct carcinoma: A disease entity with promising new treatment options, J Clin Oncol, 29, e473, 10.1200/JCO.2010.32.8351

Persson, 2009, Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck, Proc Natl Acad Sci U S A, 106, 18740, 10.1073/pnas.0909114106

Mitani, 2010, Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance, Clin Cancer Res, 16, 4722, 10.1158/1078-0432.CCR-10-0463

Tonon, 2003, t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a notch signaling pathway, Nat Genet, 33, 208, 10.1038/ng1083

Tirado, 2007, CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior, Genes Chromosomes Cancer, 46, 708, 10.1002/gcc.20458

Postema, 2004, Accuracy of fine-needle aspiration cytology of salivary gland lesions in the Netherlands Cancer Institute, Head Neck, 26, 418, 10.1002/hed.10393

Razfar, 2010, Positron emission tomography-computed tomography adds to the management of salivary gland malignancies, Laryngoscope, 120, 734, 10.1002/lary.20829

Garden, 1997, Postoperative radiotherapy for malignant tumors of the parotid gland, Int J Radiat Oncol Biol Phys, 37, 79, 10.1016/S0360-3016(96)00464-6

Terhaard, 2004, Salivary gland carcinoma: Independent prognostic factors for locoregional control, distant metastases, and overall survival: Results of the Dutch head and neck oncology cooperative group, Head Neck, 26, 681, 10.1002/hed.10400

Hanna, 2003, Malignant tumors of the salivary glands, in Myers EN, Suen JY, Myers JN, Hanna EY (eds): Cancer of the Head and Neck, Philadelphia, PA, Saunders

Armstrong, 1990, Malignant tumors of major salivary gland origin, Arch Otolaryngol Head Neck Surg, 116, 290, 10.1001/archotol.1990.01870030054008

North, 1990, Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy, Int J Radiat Oncol Biol Phys, 18, 1319, 10.1016/0360-3016(90)90304-3

Terhaard, 2005, The role of radiotherapy in the treatment of malignant salivary gland tumors, Int J Radiat Oncol Biol Phys, 61, 103, 10.1016/j.ijrobp.2004.03.018

Bissett, 1988, Malignant submandibular gland tumors, Am J Clin Oncol, 11, 46, 10.1097/00000421-198802000-00010

Chen, 2006, Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: Prognostic features of recurrence, Int J Radiat Oncol Biol Phys, 66, 152, 10.1016/j.ijrobp.2006.04.014

Shah, 2011, Parotid cancer treatment with surgery followed by radiotherapy in Oxford over 15 years, Ann R Coll Surg Engl, 93, 218, 10.1308/003588411X565969

Garden, 1994, Postoperative radiation therapy for malignant tumors of minor salivary glands, Cancer, 73, 2563, 10.1002/1097-0142(19940515)73:10<2563::AID-CNCR2820731018>3.0.CO;2-X

Parsons, 1996, Management of minor salivary gland carcinomas, Int J Radiat Oncol Biol Phys, 35, 443, 10.1016/S0360-3016(96)80005-8

Laramore, 1993, Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council, Int J Radiat Oncol Biol Phys, 27, 235, 10.1016/0360-3016(93)90233-L

Schulz-Ertner, 2003, Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas, Int J Radiat Oncol Biol Phys, 56, 391, 10.1016/S0360-3016(02)04511-X

Wang, 1991, Photon irradiation of unresectable carcinomas of salivary glands, Int J Radiat Oncol Biol Phys, 21, 569, 10.1016/0360-3016(91)90672-Q

Gabriele, 1995, Hyperthermia and radiation therapy for inoperable or recurrent parotid carcinoma, Cancer, 75, 908, 10.1002/1097-0142(19950215)75:4<908::AID-CNCR2820750403>3.0.CO;2-Z

Pommier, 2006, Proton beam radiation therapy for skull base adenoid cystic carcinoma, Arch Otolaryngol Head Neck Surg, 132, 1242, 10.1001/archotol.132.11.1242

Freeman, 1990, Intraoperative radiotherapy of head and neck cancer, Arch Otolaryngol Head Neck Surg, 116, 165, 10.1001/archotol.1990.01870020041011

Armstrong, 1992, The indications for elective treatment of the neck in cancer of the major salivary glands, Cancer, 69, 615, 10.1002/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9

Garden, 1995, The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation, Int J Radiat Oncol Biol Phys, 32, 619, 10.1016/0360-3016(95)00122-F

Papaspyrou, 2011, Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review, Head Neck, 33, 905, 10.1002/hed.21458

Laurie, 2006, Systemic therapy in the palliative management of advanced salivary gland cancers, J Clin Oncol, 24, 2673, 10.1200/JCO.2005.05.3025

Surakanti, 2008, Salivary gland malignancies: The role for chemotherapy and molecular targeted agents, Semin Oncol, 35, 309, 10.1053/j.seminoncol.2008.03.009

Vattemi, 2008, Systemic therapies for recurrent and/or metastatic salivary gland cancers, Expert Rev Anticancer Ther, 8, 393, 10.1586/14737140.8.3.393

Rizk, 2007, Activity of chemotherapy in the palliative treatment of salivary gland tumors: Review of the literature, Eur Arch Otorhinolaryngol, 264, 587, 10.1007/s00405-007-0297-x

Gilbert, 2006, Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group, Head Neck, 28, 197, 10.1002/hed.20327

van Herpen, 2008, Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982), Eur J Cancer, 44, 2542, 10.1016/j.ejca.2008.08.014

Laurie, 2010, A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: A trial of the NCIC Clinical Trials Group, Cancer, 116, 362, 10.1002/cncr.24745

Tanvetyanon, 2009, Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma, Arch Otolaryngol Head Neck Surg, 135, 687, 10.1001/archoto.2009.70

Pederson, 2010, Chemoreirradiation for recurrent salivary gland malignancies, Radiother Oncol, 95, 308, 10.1016/j.radonc.2010.03.006

Haddad, 2006, Chemoradiotherapy for adenoid cystic carcinoma: Preliminary results of an organ sparing approach, Am J Clin Oncol, 29, 153, 10.1097/01.coc.0000203756.36866.17

Katori, 2006, Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma, Acta Otolaryngol, 126, 1309, 10.1080/00016480600818070

Haddad, 2003, Herceptin in patients with advanced or metastatic salivary gland carcinomas, Oral Oncol, 39, 724, 10.1016/S1368-8375(03)00097-6

Glisson, 2005, Phase II trial of gefitinib in patients with incurable salivary gland cancer, J Clin Oncol, 23, 508s, 10.1200/jco.2005.23.16_suppl.5532

Pfeffer, 2007, A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands, Oral Oncol, 43, 33, 10.1016/j.oraloncology.2005.12.026

Locati, 2009, Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study, Oral Oncol, 45, 574, 10.1016/j.oraloncology.2008.07.010

Vidal, 2009, Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib, Head Neck, 31, 1006, 10.1002/hed.21052

Williams, 2010, Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: Empirical and therapeutic significance, Clin Cancer Res, 16, 2266, 10.1158/1078-0432.CCR-09-0238